The temporal scheme that we have used was inspired by previous successful preclinical studies on radio-immunotherapy combinations using the PD1/PD-L1 axis blockade [31], [32], but it might not be suitable for the case of GBM and MBRT. Here, CD274 is linked to glioblastoma.